The Global Point-of-Care Molecular Diagnostics Market is projected to grow at a CAGR of 10.2% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals ...

Cold mornings, radiators humming, and a chorus of snorts from the sofa raise quiet doubts in countless British homes. As ...

The global clinical diagnostics industry is entering a new era of technological progress and healthcare transformation.

The global rapid food safety testing market, valued at $19.66 billion in 2025, is forecast to grow at a CAGR of 9.7%, reaching $31.22 billion by 2030. Increasing demand for convenience foods, subject ...

The panels employ PCR techniques to test for numerous gastrointestinal bacterial pathogens using one stool swab.

In a profession where the stakes are high and every advantage matters, creatine should be considered an evidence-based tool ...

First study to evaluate HER2DX in a randomized trial focused exclusively on older individuals (aged 70-80 years). HER2DX independently predicts long-term survival outcomes in patients treated ...

Doctors warn that at-home gut microbiome tests are largely unregulated, often unreliable and offer little actionable value ...

HER2DX is a prognostic, predictive assay based on clinical and genomic data. The test integrates clinical information (i.e.

The best way to protect against pertussis is immunization. Parents should ensure children are up-to-date on pertussis immunizations, and pregnant women and others who will be around newborns should ...